Myrexis

Myrexis (formerly known as Myriad Pharmaceuticals) is a molecular biopharmaceutical company. It discovers, develops, and commercializes therapies for the treatment of cancer. The company is also engaged in identifying, evaluating, and making financial investments in life sciences assets.